WallStreetZenWallStreetZen

NYSE: RBOT
Vicarious Surgical Inc Stock Forecast, Predictions & Price Target

Analyst price target for RBOT

Based on 3 analysts offering 12 month price targets for Vicarious Surgical Inc.
Min Forecast
$0.40+43.37%
Avg Forecast
$0.67+139.07%
Max Forecast
$1.00+258.42%

Should I buy or sell RBOT stock?

Based on 3 analysts offering ratings for Vicarious Surgical Inc.
Hold
Strong Buy
0 analysts 0%
Buy
0 analysts 0%
Hold
3 analysts 100%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their RBOT stock forecasts and price targets.

RBOT stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2024-03-05
lockedlocked$00.00+00.00%2023-12-04
lockedlocked$00.00+00.00%2023-11-14

1 of 1

Forecast return on equity

Is RBOT forecast to generate an efficient return?
Company
N/A
Industry
N/A
Market
35.66%

Forecast return on assets

Is RBOT forecast to generate an efficient return on assets?
Company
N/A
Industry
N/A

RBOT revenue forecast

What is RBOT's revenue in the next 1 years based on estimates from 1 analyst?
Avg 1 year Forecast
$35.0M

RBOT vs Medical Device Stocks

TickerPricePrice TargetUp/downsideConsensus
RBOT$0.28$0.67+139.07%Hold
IRIX$3.02N/AN/A
NSPR$2.14$4.50+110.18%Strong Buy
APYX$1.38$5.00+262.32%Strong Buy
MOVE$0.48N/AN/A

Vicarious Surgical Stock Forecast FAQ

Is Vicarious Surgical Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 3 Wall Street analysts covering (NYSE: RBOT) stock is to Hold RBOT stock.

Out of 3 analysts, 0 (0%) are recommending RBOT as a Strong Buy, 0 (0%) are recommending RBOT as a Buy, 3 (100%) are recommending RBOT as a Hold, 0 (0%) are recommending RBOT as a Sell, and 0 (0%) are recommending RBOT as a Strong Sell.

If you're new to stock investing, here's how to buy Vicarious Surgical stock.

What is RBOT's revenue growth forecast for 2027-2027?

(NYSE: RBOT) Vicarious Surgical's forecast annual revenue growth rate of N/A is not forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 8.34%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.23%.

Vicarious Surgical's revenue in 2024 is $0.

In 2027, RBOT is forecast to generate $6,151,308,555 in revenue, with the lowest revenue forecast at $6,151,308,555 and the highest revenue forecast at $6,151,308,555.

What is RBOT's forecast return on assets (ROA) for 2024-2027?

(NYSE: RBOT) forecast ROA is N/A, which is lower than the forecast US Medical Devices industry average of N/A.

What is RBOT's Price Target?

According to 3 Wall Street analysts that have issued a 1 year RBOT price target, the average RBOT price target is $0.67, with the highest RBOT stock price forecast at $1.00 and the lowest RBOT stock price forecast at $0.40.

On average, Wall Street analysts predict that Vicarious Surgical's share price could reach $0.67 by Mar 5, 2025. The average Vicarious Surgical stock price prediction forecasts a potential upside of 139.07% from the current RBOT share price of $0.28.

What is RBOT's forecast return on equity (ROE) for 2024-2027?

(NYSE: RBOT) forecast ROE is N/A, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.